Opus Genetics Inc (IRD)

Finanzdaten der Opus Genetics Inc-Aktie (IRD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-07-01
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	65.00%0.76	2.16	3.87	3.08	2.88
Operating Expenses	4.32%17.24	16.52	15.32	11.39	11.79
Operating Income/Loss	14.73%-16.48	-14.36	-11.45	-8.31	-8.91
Income/Loss From Continuing Operations Before Tax	87.64%-8.10	-65.54	-16.52	-17.45	-7.42
Income Tax Expense/Benefit	-	-	-	-	-
	87.64%-8.10	-65.54	-16.52	-17.45	-7.42
Attributable To Parent	87.64%-8.10	-65.54	-16.52	-17.45	-7.42
Basic Average Shares	9.89%95.48	86.89	-	70.64	63.38
Diluted Average Shares	28.19%111.38	86.89	-	70.64	63.38
Basic Earnings Per Share	89.33%-0.08	-0.75	-	-0.25	-0.12
Diluted Earnings Per Share	81.33%-0.14	-0.75	-	-0.25	-0.12